Value of early case assessment to understand impact of litigation. Practical tips and strategies at each stage of the “life cycle” of a patent litigation. How to build your case methodically, ...

An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and Appeal Board’s (PTAB’s) approach to discretionary denials of inter partes review ...

Patent litigation reform could accelerate US biosimilar market entry, which lags behind the EU due to protracted legal processes. Biosimilar manufacturers face options like pre-clearance, "at-risk" ...

The U.S. Court of Federal Claims held that pharmaceutical patent litigation expenses under the Hatch-Waxman Act were deductible business expenses under Sec. 162. The court arrived at this conclusion ...

August 31, 2023 - Patent litigation over pharmaceuticals and biologics involves a complex interplay between patent law, court procedures and Food and Drug Administration (FDA)/regulatory regimes. When ...

While both types of litigation seek to protect innovation that often requires counsel to have specialized technical expertise—trade secret and patent cases diverge substantially in their legal ...

“The party seeking funding or insurance should be willing to address with full candor both the strengths and weaknesses of the case during the diligence process.” When I was in law school, my business ...

“The factors driving perception that patents have lost their value are certainly relevant and have had a substantial impact on patent litigation [but] none of these factors, alone or in combination, ...

This comprehensive directory highlights the thriving intellectual property (IP) legal landscape in New York City, showcasing over 100 boutique and midsized firm ...

Patent attorneys who have primarily focused on work at the Patent Trial and Appeal Board are pivoting, dusting off old skills or considering new forums as they adjust to significant changes instituted ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today the commencement of litigation with the United States Food and Drug ...